C
Name | Dosage form | ATC code |
---|---|---|
![]() Accordin Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
100 mg/ml, 5 ml № 5, № 10, № 100 | С01ЕВ22 |
![]() Amiodarone Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,2 g № 30 | C01BD01 |
![]() Amlodipine Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
5 mg № 30 | C08CA01 |
![]() Amlodipine Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
10 mg № 30 | C08CA01 |
![]() Amlodipine Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
5 mg №60 | C08CA01 |
![]() Amlodipine Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
5 mg №90 | C08CA01 |
![]() Amlodipine Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
10 mg №60 | C08CA01 |
![]() Amlodipine Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
10 mg №90 | C08CA01 |
![]() Anaesthesolum Suppositories Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
№ 5, № 10 | C05AD |
![]() Ascorutin Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
№ 50, № 800 | C05CA51 |
![]() Beladonna Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,015 g № 10 | C05AX |
![]() Bethiolum Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
№ 10 | C05AX03 |
![]() Enalapril Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,01 g № 50 | C09AA02 |
![]() Enalapril Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,01 g № 20 | C09AA02 |
![]() Enalapril Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,01 g № 90 | C09AA02 |
![]() Larginus Oral solution Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
100 мл | С01E |
|
15 mg № 10 | C05AX |
|
№ 5, № 10 | C05AD |
![]() Nicotinic acid Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
50 mg № 50 | C04AC01 |
![]() Nifedipine Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
20 mg № 50 | C08CA05 |
![]() Nifedipine Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
10 mg № 50 | C08CA05 |
![]() Nitroglycerine Sublingual tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,5 mg № 40 | C01DA02 |
![]() Nitrogranulong Prolonged release tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
5,2 mg № 10, № 50 | C01DA02 |
![]() Nitrogranulong Prolonged release tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
2,9 mg № 10, № 50 | C01DA02 |
![]() Oftalek Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
10 mg/ml 1 ml №10 | С05СX |
![]() Pentoxifylline Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
100 mg № 10, № 50 | C04AD03 |
![]() Proctozol Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
№ 5, № 10 | C05AD51 |
![]() Propolis Suppositories Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,1 g № 5, № 10 | C05AX |
![]() Riboxin Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
200 mg № 10, № 50 | C01EB |
![]() Torasemide Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
5 mg/ml 2 ml, 4 ml № 5, № 10, № 100 | C03CA04 |